Tumor Prostaglandins and Estrogen Receptors: Prediction of Survival in Patients with Early Breast Cancer

  • A. Bennett
  • M. Baum
  • D. Cooper
  • I. F. Stamford
  • A. J. Wilson
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

Our initial study of breast tumor prostaglandins concerned their relationship to the spread of the cancer to bone. This investigation, in which patient recruitment was started in 1974 and ended in 1978, was later extended to an examination of the relationship between tumor prostaglandins and patient survival. We found a highly significant inverse relationship (Bennett et al 1980) between the time to death and tumor PG-LM (prostaglandin-like material, so-called because the extracted prostaglandins were bioassayed against PGE2 on rat gastric fundus) (Bennett et al 1973).

Keywords

Breast Cancer Early Breast Cancer Estrogen Receptor Status Human Primary Breast Cancer Estrogen Receptor Content 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Badwe, R. A., Gregory, W. M., Chaudary, M. A., Richards, M. A., Bentley, A. E., Rubens, R. D., and Fentiman, I., 1991, Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet, 337: 1261.PubMedCrossRefGoogle Scholar
  2. Bennett, A., Jarosik, C., Sanger, G. J., and Wilson, D. E., 1980, Antagonism of prostanoid-induced contractions of rat gastric fundus muscle by SC-19220, sodium meclofenamate, indomethacin or trimethoquinol. Br. J. Pharmacol., 71: 169.PubMedGoogle Scholar
  3. Bennett, A., Stamford, I. F., Berstock, D. A., Dische, F., Singh, L., and A’Hern, R. P., 1989, Breast cancer, prostaglandins and patient survival. Br. J. Cancer, 59: 268.PubMedCrossRefGoogle Scholar
  4. Bennett, A., Stamford, I. F., and Unger, W. G., 1973, Prostaglandin E2 and gastric acid secretion in man. J. Physiol., 229: 349.PubMedGoogle Scholar
  5. Bennett, A., Berstock, D. A., Harris, M., Raja, B., Rowe, D. R., Stamford, I. F., and Wright, J. E., Prostaglandins and their relationship to malignant and benign human breast tumours. In: Advances in Prostaglandin and Thromboxane Research, Vol. 6, B. Samuelsson, PW Ramwell and R Paoletti, eds., Raven Press, New York, pp 595–600 (1980).Google Scholar
  6. Korenman, S. G., and Dukes, B. A., 1970, Specific estrogen binding by the cytoplasm of human breast carcinoma. J. Clin. Endocrinol. Metab., 30: 639.PubMedCrossRefGoogle Scholar
  7. Lee, E., and Desu, M., 1972, A computer program for comparing K samples with right-censored data. Computer Prog. Biomed., 2: 315.CrossRefGoogle Scholar
  8. Malachi, T., Chaimoff, C. H., Feller, N., and Halbrecht, I., 1981, Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients. J. Cancer Res. Clin. Oncol., 102: 71.PubMedCrossRefGoogle Scholar
  9. Rolland, P. H., Martin, P. M., Jacquemier, J., Rolland, A. M., and Toga, M. 1980, Prostaglandins in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst., 64: 1061.PubMedGoogle Scholar
  10. Unger, W. G., Stamford, I. F., and Bennett, A., 1971, Extraction of prostaglandins from human blood. Nature, 223: 336.CrossRefGoogle Scholar
  11. Van Dam, P. A., Vergoete, I. B., Laekeman, G. M., Keersmaekers, G. H., Uyttenbroeck, F. L., and Herman, A.G., 1989, Prognostic value of prostaglandin F2« concentrations in breast carcinoma. J. Clin. Pathol., 42: 1046.PubMedCrossRefGoogle Scholar
  12. Vergoete, I. B., Laekman, G. M., Keersmaekers, G. H., Uyttenbroeck, F. L., Vanderheyden, J. S., Albertyn, G. P., Haensch, C. F., DeRoy, G. J., and Herman, A. G., 1985, Prostaglandin F2« in benign and malignant breast tumours. Br. J. Cancer, 51: 827.CrossRefGoogle Scholar
  13. Watson, D. M. A., Kelly, R. W., and Miller, W. R., 1987, Prostaglandins and prognosis in human breast cancer. Br. J. Cancer, 56: 367.PubMedCrossRefGoogle Scholar
  14. Wilson, A. J., Baum, M., Bennett, A., Griffiths, K., Nicholson, R.I., and Stamford, I. F., 1980, Lymph node status, prostaglandins and oestrogen receptors are independent prognostic variables in human primary breast cancer. Clin. Oncol., 6: 379.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • A. Bennett
    • 1
  • M. Baum
    • 1
  • D. Cooper
    • 1
  • I. F. Stamford
    • 1
  • A. J. Wilson
    • 1
  1. 1.Department of Surgery, The Rayne InstituteKing’s College School of Medicine and DentistryLondonEngland

Personalised recommendations